Skip to main content
← Back to Lupus

Clinician handoff

Lupus

Designed for a 60-second scan in primary care. Use this to explain why this theory fits, what would weaken it, and which tests are most worth discussing.

Why this still fits

I have symptoms that make me want to rule out lupus - brain fog alongside fatigue that comes in flares, joint involvement, or a prior positive ANA. I want to check disease activity markers and understand what would strengthen or weaken the case for specialist evaluation.

What would weaken it

  • -No flare-linked immune story, no lupus features, and no lab or clinical support for active systemic disease.
  • -The fog does not track with inflammation, pain, rash, fever, or other lupus-related activity.
  • -Another autoimmune or non-autoimmune cause explains the pattern more convincingly.

Key points to communicate

  • •I want to know whether lupus activity is truly affecting cognition or whether the fog is coming from a nearby overlap.
  • •Please separate lupus-related brain effects from anemia, sleep problems, medication effects, and mood changes.
  • •If lupus is part of the answer, I want to know what markers or symptom changes matter most.

Bring this to the visit

  • •Recent lupus labs: anti-dsDNA, complement levels (C3, C4), CBC, CRP.
  • •Current SLEDAI score or disease activity assessment if available.
  • •Medication list: hydroxychloroquine, immunosuppressants, steroids with doses.
  • •A timeline of fog relative to lupus flares and medication changes.

Useful screening structure

  • -SLEDAI-2K for disease activity assessment.
  • -ACR/EULAR classification criteria review.
  • -PHQ-9 since depression is very common with lupus and independently worsens fog.

Tests and measurements to discuss

Lupus Activity Assessment (anti-dsDNA, complement C3/C4, CBC, CMP, ESR/CRP, urinalysis)

What this helps clarify: Specific for systemic lupus erythematosus (SLE)

Range context

Negative

How to use the result

Save the result with date and symptoms from the same week.

Antiphospholipid antibody panel (anticardiolipin, anti-beta2-glycoprotein I, lupus anticoagulant)

Neuropsychiatric Lupus Evaluation (if indicated: brain MRI, neuropsych testing, anti-ribosomal P)

What this helps clarify: Tests memory, attention, executive function, processing speed

Range context

Comprehensive battery

How to use the result

Save the result with date and symptoms from the same week.

Questions to ask directly

  • •Is the fog from active lupus inflammation, medication side effects, or a co-occurring issue?
  • •Should we check for antiphospholipid antibodies if cognitive symptoms are prominent?
  • •Are there co-occurring causes worth screening: thyroid, anemia, vitamin D, sleep?
  • •Would adjusting immunosuppression help the cognitive symptoms if disease is active?

Functional impact snapshot

  • -Rate fog severity against disease activity markers: do they rise and fall together?
  • -Track whether steroid dose changes shift the fog pattern (steroids can cause fog too).
  • -Note which cognitive domains are worst and whether they correlate with flare severity.

Escalate instead of self-managing if

  • •Seizures, psychosis, or severe confusion suggesting CNS lupus.
  • •New focal neurological deficits needing urgent imaging.
  • •Rapidly declining kidney function (lupus nephritis) with cognitive symptoms.

Peer-reviewed references

  1. 1. HTTPS://RHEUMATOLOGY.ORG/LUPUS-GUIDELINE [DOI]
  2. 2. Hanly JG et al. Neuropsychiatric events in SLE: a longitudinal analysis. Ann Rheum Dis. 2020;79(3):356-362. PMID: 31915121 [DOI]
  3. 3. Bertsias GK et al. EULAR recommendations for SLE with neuropsychiatric manifestations. Ann Rheum Dis. 2010;69(12):2074-82. PMID: 20724309 [DOI]